Literature DB >> 3947513

Indirect mechanism of oestradiol stimulation of cell proliferation of human breast cancer cell lines.

A E Lykkesfeldt, P Briand.   

Abstract

The human breast cancer cell line MCF-7 requires oestrogen to produce and promote growth of tumours in athymic mice. In vitro, however, MCF-7 cells proliferate rapidly without supply of oestrogen (Briand & Lykkesfeldt, 1984). Oestrogen stimulation of proliferation of MCF-7 cells can be achieved when the cells are grown at high concentration of newborn calf serum (NCS, 10%) or oestrogen deprived foetal calf serum (10%). The stimulation involves an abolishment of inhibitory activity present in the serum. The oestradiol stimulated cultures grow rapidly for a much longer time period and attain a much higher cell density than the unstimulated cultures. Oestrogen is specific for the promotion of cell proliferation and only oestrogen receptor positive cell lines with a functional oestrogen receptor mechanism can be stimulated. We assume that oestradiol acts directly on the cells and via the oestrogen receptor mechanism induces the synthesis of a substance which abolishes the inhibitory activity in serum. We call this mechanism of action an indirect stimulation of cell proliferation. A similar mechanism may exist in vivo since we find that serum from athymic mice contains a growth inhibitory activity towards MCF-7 cells and the inhibitory effect can be abolished by oestradiol.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3947513      PMCID: PMC2001475          DOI: 10.1038/bjc.1986.5

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  17 in total

1.  Serum regulation of the estrogen responsiveness of the human breast cancer cell line MCF-7.

Authors:  M J Page; J K Field; N P Everett; C D Green
Journal:  Cancer Res       Date:  1983-03       Impact factor: 12.701

2.  Effect of estradiol on human breast cancer cells in culture.

Authors:  P Darbre; J Yates; S Curtis; R J King
Journal:  Cancer Res       Date:  1983-01       Impact factor: 12.701

3.  Estrogens stimulate cell proliferation and induce secretory proteins in a human breast cancer cell line (T47D).

Authors:  D Chalbos; F Vignon; I Keydar; H Rochefort
Journal:  J Clin Endocrinol Metab       Date:  1982-08       Impact factor: 5.958

4.  The effects of 17 beta estradiol and tamoxifen on the ZR-75-1 human breast cancer cell line in defined medium.

Authors:  J C Allegra; M E Lippman
Journal:  Eur J Cancer       Date:  1980-08       Impact factor: 9.162

5.  Growth of a human mammary tumour cell line in a serum-free medium.

Authors:  D Barnes; G Sato
Journal:  Nature       Date:  1979-10-04       Impact factor: 49.962

6.  The effects of estrogens and antiestrogens on hormone-responsive human breast cancer in long-term tissue culture.

Authors:  M Lippman; G Bolan; K Huff
Journal:  Cancer Res       Date:  1976-12       Impact factor: 12.701

7.  Steroid stimulation of plasminogen activator production in a human breast cancer cell line (MCF-7).

Authors:  W B Butler; W L Kirkland; T L Gargala; N Goran; W H Kelsey; P J Berlinski
Journal:  Cancer Res       Date:  1983-04       Impact factor: 12.701

8.  Mechanism of estrogen action on cellular proliferation: evidence for indirect and negative control on cloned breast tumor cells.

Authors:  A M Soto; C Sonnenschein
Journal:  Biochem Biophys Res Commun       Date:  1984-08-16       Impact factor: 3.575

9.  Estrogen and the growth of breast cancer: new evidence suggests indirect action.

Authors:  S M Shafie
Journal:  Science       Date:  1980-08-08       Impact factor: 47.728

10.  Response to estrogen by the human mammary carcinoma cell line CAMA-1.

Authors:  B S Leung; S Qureshi; J S Leung
Journal:  Cancer Res       Date:  1982-12       Impact factor: 12.701

View more
  18 in total

1.  Estrogen mitogenic action. III. is phenol red a "red herring"?

Authors:  J E Moreno-Cuevas; D A Sirbasku
Journal:  In Vitro Cell Dev Biol Anim       Date:  2000 Jul-Aug       Impact factor: 2.416

2.  Increased proteasome-dependent degradation of estrogen receptor-alpha by TGF-beta1 in breast cancer cell lines.

Authors:  Trevor A Petrel; Robert W Brueggemeier
Journal:  J Cell Biochem       Date:  2003-01-01       Impact factor: 4.429

3.  Role of proliferation and apoptosis in net growth rates of human breast cancer cells (MCF-7) treated with oestradiol and/or tamoxifen.

Authors:  P E Budtz
Journal:  Cell Prolif       Date:  1999-10       Impact factor: 6.831

4.  A new diploid nontumorigenic human breast epithelial cell line isolated and propagated in chemically defined medium.

Authors:  P Briand; O W Petersen; B Van Deurs
Journal:  In Vitro Cell Dev Biol       Date:  1987-03

5.  Estrogen mitogenic action. I. Demonstration of estrogen-dependent MTW9/PL2 carcinogen-induced rat mammary tumor cell growth in serum-supplemented culture and technical implications.

Authors:  J E Moreno-Cuevas; D A Sirbasku
Journal:  In Vitro Cell Dev Biol Anim       Date:  2000 Jul-Aug       Impact factor: 2.416

6.  Estrogen mitogenic action. ii. negative regulation of the steroid hormone-responsive growth of cell lines derived from human and rodent target tissue tumors and conceptual implications.

Authors:  D A Sirbasku; J E Moreno-Cuevas
Journal:  In Vitro Cell Dev Biol Anim       Date:  2000 Jul-Aug       Impact factor: 2.416

7.  Immunohistochemical analysis of the topographical relationship between the estrogen- and progesterone receptor in five human breast cancers. A simultaneous demonstration of both nuclear receptors in the same section by using a computer-assisted image processing.

Authors:  H Bonkhoff; N Wernert
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1989

8.  Cell cycle synchronization induced by tamoxifen and 17 beta-estradiol on MCF-7 cells using flow cytometry and a monoclonal antibody against bromodeoxyuridine.

Authors:  S Bruno; A Di Vinci; E Geido; W Giaretti
Journal:  Breast Cancer Res Treat       Date:  1988-07       Impact factor: 4.872

9.  Influence of L-thyroxine, L-triiodothyronine, thyroid stimulating hormone, or estradiol on the cell kinetics of cultured mammary cancer cells.

Authors:  Y de Launoit; R Kiss
Journal:  In Vitro Cell Dev Biol       Date:  1989-07

Review 10.  The future of new pure antiestrogens in clinical breast cancer.

Authors:  A E Wakeling
Journal:  Breast Cancer Res Treat       Date:  1993       Impact factor: 4.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.